Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 584.29 BATS BZX Real-Time Price As of 12:45pm ET |  -15.46 / -2.58%Today’s Change | 294.86 Today|||52-Week Range 664.64 | +55.61% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 599.75 |
| Today’s open | 601.01 |
| Day’s range | 583.06 - 601.10 |
| Volume | 13,640 |
| Average volume (3 months) | 909,504 |
| Market cap | $63.8B |
Data as of 12:45pm ET, 10/19/2020
Growth & Valuation
| Earnings growth (last year) | -14.46% |
| Earnings growth (this year) | +19.36% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +17.18% |
| P/E ratio | 22.6 |
| Price/Sales | 5.47 |
| Price/Book | 5.96 |
Competitors
Data as of 12:46pm ET, 10/19/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $7.01 |
| Annual revenue (last year) | $7.9B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 26.91% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
